GLP1 Gold Rush: Weight Loss Drugs' Cancer Link, Ozempic vs Mounjaro, Invest in Your Health & Wealth!
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
GLP1 Gold Rush: Weight Loss Drugs' Cancer Link, Ozempic vs Mounjaro, Invest in Your Health & Wealth!
-
Lu par :
-
De :
À propos de cette écoute
Episode 27
00:00 Market Overview and V-Shaped Recovery
06:44 Investing Strategies and TFSA Benefits
12:43 Health and Wealth: The Importance of Advocacy
18:42 Pharmaceutical Stocks and Market Dynamics
24:37 The Impact of GLP-1 Drugs on Cancer Risk
30:43 Understanding Muscle Loss with GLP-1s
35:40 The Importance of Exercise and Personal KPIs
Host descriptions:
Catherine Murray, a business newscaster and former Wall Street professional at Goldman, William Blair and Deutsche bank.
Dr. Melissa Hershberg, a medical practitioner with a specialized interest in preventive health, weight loss and aesthetic medicine.
Disclaimer: for entertainment purposes only, please do your own research, your own homework and consult with a financial advisor for investment discussions. In addition to consulting with your Family Doctor, Physician, GP or other health care providers before making any health and beauty decisions
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
